Genmab AS (GNMSF)
214.68
+4.97
(+2.37%)
USD |
OTCM |
Jan 03, 16:00
Genmab Market Cap: 13.64B for Jan. 3, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Ascendis Pharma AS | 8.397B |
Galecto Inc | 7.507M |
Evaxion Biotech AS | 5.338M |
IO Biotech Inc | 61.61M |
Market Cap Related Metrics
PE Ratio | 20.40 |
PS Ratio | 4.844 |
PEG Ratio | 1.365 |
Price to Book Value | 2.852 |
Price to Free Cash Flow | 14.58 |
Price | 214.68 |
Earnings Yield | 4.90% |
PEGY Ratio | 1.365 |
Operating PE Ratio | 14.81 |
Normalized PE Ratio | 18.05 |